Retail investors channeled ₹38,440 crore into equity mutual funds in April, a slight dip from March, amid oil price uncertainty. SIP collections also saw a decrease. Despite this, overall assets under management rose significantly due to debt fund inflows and equity market gains.
Dr Reddy’s Laboratories Q4 Results: Cons PAT falls 86% YoY to Rs 221 crore, revenue dips 12%; Rs 8 per share dividend announced
Dr Reddy’s Laboratories Q4 Results: Dr. Reddy’s Laboratories reported a consolidated net profit at Rs 221 crore in the March-ended quarter versus Rs 1,587 crore